Effects of Pulsed Electromagnetic Fields on Bone Mass and Wnt/β-Catenin Signaling Pathway in Ovariectomized Rats

Archives of Medical Research

Volumn 43, Issue 4, 2012, Pages 274-282

  Zhou, Jun ^a   He, Hongchen ^a   Yang, Lin ^a   Chen, Shiju ^a   Guo, Hua ^a   Xia, Lu ^a   Liu, Huifang ^a   Qin, Yuxi ^a   Liu, Chuan ^a   Wei, Xiaofei ^a   Zhou, Yujing ^a   He, Chengqi ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Bone mass; Osteoporosis; Ovariectomy; Pulsed electromagnetic fields; Wnt catenin

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; ESTRADIOL; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; MESSENGER RNA; TRANSCRIPTION FACTOR RUNX2; WNT3A PROTEIN;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE STRENGTH; CONTROLLED STUDY; ELECTROMAGNETIC FIELD; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR; LUMBAR VERTEBRA; MORPHOMETRICS; NONHUMAN; ONCOGENE C MYC; OVARIECTOMY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRABECULAR BONE;

ABSORPTIOMETRY, PHOTON; ALKALINE PHOSPHATASE; ANIMALS; BONE DENSITY; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION THERAPY; ESTRADIOL; FEMALE; FEMUR; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; LUMBAR VERTEBRAE; MAGNETIC FIELD THERAPY; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 84864104885     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.06.002     Document Type: Article

References (47)

1. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285:785-795. National Institutes of Health.
2. Kanis J.A. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002, 359:1929-1936.
3. Lewiecki E.M. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis. J Womens Health (Larchmont) 2009, 18:1615-1626.
4. Gallacher S.J., Dixon T. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review. Calcif Tissue Int 2010, 87:469-484.
5. Garland D.E., Adkins R.H., Matsuno N.N., et al. The effect of pulsed electromagnetic fields on osteoporosis at the knee in individuals with spinal cord injury. J Spinal Cord Med 1999, 22:239-245.
6. Tabrah F., Hoffmeier M., Gilbert F., et al. Bone density changes in osteoporosis-prone women exposed to pulsed electromagnetic fields (PEMFs). J Bone Miner Res 1990, 5:437-442.
7. Chang K., Chang W.H. Pulsed electromagnetic fields prevent osteoporosis in an ovariectomized female rat model: a prostaglandin E2-associated process. Bioelectromagnetics 2003, 24:189-198.
8. Jing D., Shen G., Huang J., et al. Circadian rhythm affects the preventive role of pulsed electromagnetic fields on ovariectomy-induced osteoporosis in rats. Bone 2010, 46:487-495.
9. Lohmann C.H., Schwartz Z., Liu Y., et al. Pulsed electromagnetic field stimulation of MG63 osteoblast-like cells affects differentiation and local factor production. J Orthop Res 2000, 18:637-646.
10. De Mattei M., Caruso A., Traina G.C., et al. Correlation between pulsed electromagnetic fields exposure time and cell proliferation increase in human osteosarcoma cell lines and human normal osteoblast cells in vitro. Bioelectromagnetics 1999, 20:177-182.
11. Krishnan V., Bryant H.U., Macdougald O.A. Regulation of bone mass by Wnt signaling. J Clin Invest 2006, 116:1202-1209.
12. Gregory L.S., Kelly W.L., Reid R.C., et al. Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats. Bone 2006, 39:134-142.
13. Parfitt A.M., Drezner M.K., Glorieux F.H., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
14. Markov M.S. Pulsed electromagnetic field therapy history, state of the art and future. Environmentalist 2007, 27:465-475.
15. Yang Y.H., He C.Q., Yang L., et al. Effects of different intensity pulsed electromagnetic fields on serum estradiol of ovariectomized rats. Sichuan Da Xue Xue Bao Yi Xue Ban 2008, 39:256-258.
16. Huang L., Wang W., Xiao D., et al. Effect of pulsed electromagnetic fields of different treatment time on bone mineral density of femur in ovariectomized rats. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2008, 22:548-550.
17. He C., Wang W., Xiao D., et al. Effect of pulsed electromagnetic fields of different frequencies on serum estradiol and bone calcium content of femur in ovariectomized rats. Chin J Rehab Med 2007, 22:303-305.
18. Ke H.Z., Chen H.K., Simmons H.A., et al. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone 1997, 20:31-39.
19. Swithers S.E., McCurley M., Hamilton E., et al. Influence of ovarian hormones on development of ingestive responding to alterations in fatty acid oxidation in female rats. Horm Behav 2008, 54:471-477.
20. Luo Q., Li S.S., He C., et al. Pulse electromagnetic fields effects on serum E2 levels, chondrocyte apoptosis, and matrix metalloproteinase-13 expression in ovariectomized rats. Rheumatol Int 2009, 29:927-935.
21. Han X., Xu Y., Wang J., et al. Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats. Bone 2009, 44:942-947.
22. Henriksen K., Neutzsky-Wulff A.V., Bonewald L.F., et al. Local communication on and within bone controls bone remodeling. Bone 2009, 44:1026-1033.
23. Ulrich D., van Rietbergen B., Laib A., et al. The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 1999, 25:55-60.
24. Hernandez C.J., Keaveny T.M. A biomechanical perspective on bone quality. Bone 2006, 39:1173-1181.
25. Kikuchi A., Kishida S., Yamamoto H. Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med 2006, 38:1-10.
26. Gaur T., Lengner C.J., Hovhannisyan H., et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 2005, 280:33132-33140.
27. Monroe D.G., McGee-Lawrence M.E., Oursler M.J., et al. Update on Wnt signaling in bone cell biology and bone disease. Gene 2012, 492:1-18.
28. Bodine P.V., Komm B.S. Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord 2006, 7:33-39.
29. Hartmann C. A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol 2006, 16:151-158.
30. Boland G.M., Perkins G., Hall D.J., et al. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 2004, 93:1210-1230.
31. Pinzone J.J., Hall B.M., Thudi N.K., et al. The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood 2009, 113:517-525.
32. He X., Semenov M., Tamai K., et al. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 2004, 131:1663-1677.
33. Kikuchi A. Roles of Axin in the Wnt signalling pathway. Cell Signal 1999, 11:777-788.
34. Jho E.H., Zhang T., Domon C., et al. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002, 22:1172-1183.
35. Milat F., Ng K.W. Is Wnt signalling the final common pathway leading to bone formation?. Mol Cell Endocrinol 2009, 310:52-62.
36. He T.C., Sparks A.B., Rago C., et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
37. Piek E., Sleumer L.S., van Someren E.P., et al. Osteo-transcriptomics of human mesenchymal stem cells: accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesis. Bone 2010, 46:613-627.
38. Otto F., Thornell A.P., Crompton T., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
39. Martin T., Gooi J.H., Sims N.A. Molecular mechanisms in coupling of bone formation to resorption. Crit Rev Eukaryot Gene Expr 2009, 19:73-88.
40. Marie P.J. The molecular genetics of bone formation: implications for therapeutic interventions in bone disorders. Am J Pharmacogenomics 2001, 1:175-187.
41. Bodamyali T., Bhatt B., Hughes F.J., et al. Pulsed electromagnetic fields simultaneously induce osteogenesis and upregulate transcription of bone morphogenetic proteins 2 and 4 in rat osteoblasts in vitro. Biochem Biophys Res Commun 1998, 250:458-461.
42. Swarthout J.T., D'Alonzo R.C., Selvamurugan N., et al. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 2002, 282:1-17.
43. Niu T., Rosen C.J. The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene 2005, 361:38-56.
44. Suda T., Takahashi N., Martin T.J. Modulation of osteoclast differentiation. Endocr Rev 1992, 13:66-80.
45. Chang K., Hong-Shong Chang W., Yu Y.H., et al. Pulsed electromagnetic field stimulation of bone marrow cells derived from ovariectomized rats affects osteoclast formation and local factor production. Bioelectromagnetics 2004, 25:134-141.
46. Chang K., Chang W.H., Tsai M.T., et al. Pulsed electromagnetic fields accelerate apoptotic rate in osteoclasts. Connect Tissue Res 2006, 47:222-228.
47. Chang K., Chang W.H., Huang S., et al. Pulsed electromagnetic fields stimulation affects osteoclast formation by modulation of osteoprotegerin, RANK ligand and macrophage colony-stimulating factor. J Orthop Res 2005, 23:1308-1314.